Alshammari, T K
Alshammari, M A
Nenov, M N
Hoxha, E
Cambiaghi, M
Marcinno, A
James, T F
Singh, P
Labate, D
Li, J
Meltzer, H Y
Sacchetti, B
Tempia, F
Laezza, F
Article History
Received: 30 September 2015
Revised: 25 February 2016
Accepted: 5 March 2016
First Online: 10 May 2016
Competing interests
: HYM has served as a consultant for Forum, Lundbeck, Reviva and Sunovion; he owns stocks in Acadia Pharmaceuticals, GlaxoSmithKline and SureGene. The remaining authors declare no conflict of interest.